Table 1 List of Prioritized Variants.

From: Integrated Analysis of Whole Exome Sequencing and Copy Number Evaluation in Parkinson’s Disease

Proband ID/(Gender)

Form of PD/Consanguinity

Identified Variant

Genotype

Gene

Base Change

Amino Acid Change

Proband

Other Family Members

Criteria/prioritization

PD-1 (M)

SP/No

NOTCH4

c.2865 + 2T > C

T/C

NA

1,3,5

PD-2 (M)

SP/No

BCOR

c.478G > A

p.V160I

Hemi (A)

NA

5

PD-5 (M)

SP/No

ITM2B

c.575A > T

p.Y192F

A/T

NA

3

PD-6 (M)

FM/No

HRH4

c.145C > T

p.R49X*

C/T

Father (Aff): C/T

4

PD-13 (M)

SP/No

CELSR1

c.8006T > G

p.L2669R

T/G

NA

3

PD-16 (F)

FM/No

BSN

c.7808G > A

p.R2603Q

G/A

NA

3

PD-17 (F)

SP/No

SNAP91

c.737G > A

p.R246Q

G/A

NA

3

PD-19a (M)

FM /No

FAM174A

c.451C > T

p.R151X*

C/T

Brother (Aff): C/T

1,4

PD-23 (M)

FM /No

EIF4G1

c.2144A > G

p.K715R

A/G

NA

1,2

PD-28 (M)

NA

SPG7

c.1027A > G

p.K343E

G/G

NA

3

PD-29 (M)

SP/No

MAGI2

c.1280C > T

p.T427I

C/T

NA

3,5

PD-31 (M)

SP/Yes

ATP13A2

c.1544C > T

p.T515M

C/T

NA

2,3

PD-32 (M)

FM/No

PUM1

c.2591 + 3G > A

G/A

NA

1

PD-33 (M)

SP/Yes

CLSTN1

c.553C > G

p.Q185E*

C/G

NA

3,5

PD-34b (M)

FM/No

FAM174A

c.451C > T

p.R151X*

T/T

2 affected male siblings (C/T)

2 affected male offspring (C/T)

1,4

PD-40 (M)

SP/No

PLCB3

c.698 + 4A > T

NA

A/T

NA

5

PD-43 (M)

SP/No

EPRS

c.2513G > A

p.R838H*

G/A

NA

1,3

PD-45 (M)

SP/No

DNAJB9

c.626G > A

p.R209Q

G/A

NA

3

PD-46 (F)

FM /No

PUM1

c.2591 + 3G > A

G/A

NA

1

PD-47 (M)

FM /Yes

HEPHL1

c.1856A > G

p.N619S

A/G

Son (Aff): A/G

4

PD-53 (F)

SP/No

CLSTN3

c.1124C > T

p.T375I

C/T

NA

3

PD-56c (M)

SP/No

EIF4G1

c.2144A > G

p.K715R

A/G

NA

1,2

PD-57 (F)

SP/No

EPRS

c.2372A > G

p.Y791C

A/G

NA

1,3

PD-58 (M)

SP/Yes

NEFH

c.964C > G

p.R322G

C/G

NA

3

PD-62 (M)

SP/No

EIF4G1

c.2144A > G

p.K715R

A/G

NA

1,2

PD-64 (M)

SP/No

NOTCH4

c.3769C > T

p.Q1257X

C/T

NA

1,3

  1. SP: Sporadic, FM: Familial, NA: Information not available, or not applicable. Aff: Affected. aA heterozygous deletion of PARKIN exon3 was previously reported in this index case and his affected sibling43, confirmed by MLPA in this study. bIntrafamilial differences is observed. cA homozygous deletion of PARKIN exon3 was identified by MLPA in this study in this sample. *Reported in dbSNP (MAF recorded in Supplementary Table S1). Prioritization based on filtering pipeline summarized in Fig. 1.